Autore | Outcome | Units | REBOA | Controla | p value |
---|---|---|---|---|---|
Cryoprecipitate | |||||
Dubose 2016 [24] | Cryoprecipitate 24 h | Median (IQR) | 1 (11) | 0 (1) | 0.14 |
Garcia 2020 [25] | Cryoprecipitate 6 h | Median (IQR) | 6.5 (0–10) | 0 (0–0) | 0.21 |
Crystalloids | |||||
Garcia 2020 [25] | Crystalloids 24 h millilitres | Median (IQR) | 4649 (3290–6329) | 4420 (2705–6350) | 0.13 |
Dubose 2016 [24] | Crystalloids 24 h litres | Median (IQR) | 4 (5) | 3 (5) | 0.12 |
Plasma | |||||
Joseph 2019 [27] | Plasma 24 h | Median (IQR) | 9 (6–20) | 10 (7–20) | 0.17 |
Brenner 2018 [23] | Plasma 24 h | Median (IQR) | 9 (16) | 4 (9) | 0.11 |
DuBose 2016 [24] | Plasma 24 h | Median (IQR) | 14.5 (18) | 6 (18) | < 0.001 |
Joseph 2019 [27] | Plasma 4 h | Median (IQR) | 3 (2–5) | 3 (2–6) | 0.001 |
Garcia 2020 [25] | Plasma 6 h | Median (IQR) | 4 (2.5–6) | 0 (0–4) | < 0.001 |
Platelets | Â | ||||
Joseph 2019 [27] | Platelets 24 h | Median (IQR) | 7 (3–13) | 8 (3–12) | < 0.001 |
DuBose 2016 [24] | Platelets 24 h | Median (IQR) | 5.5 (12) | 1.5 (11) | 0.5 |
Joseph 2019 [27] | Platelets 4 h | Median (IQR) | 4 (3–9) | 4 (3–8) | 0.05 |
Garcia 2020 [25] | Platelets 6 h | Median (IQR) | 0.5 (0–6) | 0 (0–0) | 0.05 |
PRBCs | |||||
Joseph 2019 [27] | PRBCs 24 h | Median (IQR) | 9 (5–20) | 10 (4–21) | 0.3988 |
Brenner 2018 [23] | PRBCs 24 h | Median (IQR) | 10 (21) | 7.8 (10) | 0.654 |
DuBose 2016 [24] | PRBCs 24 h | Median (IQR) | 20.5 (18) | 13.5 (18) | 0.343 |
Joseph 2019 [27] | PRBCs 4 h | Median (IQR) | 6 (3–8) | 7 (3–9) | 0.872 |
Garcia 2020 [25] | PRBCs 6 h | Median (IQR) | 5 (3–9) | 2 (0–4) | 0.149 |
Total amount of transfusion | |||||
Aso 2016 [22] | Total amount of transfusion within 1 d after admission: average (SD), mL | media (sd) | 2.396 (1.872) | 2.820 (2.782) | 0.697 |
Transfusion in number of patients | |||||
Abe 2016 [21] | Transfusion in number of patients | n (%) | 542 (85%) | 197 (74%) | 0.001 |
Yamamoto 2019 [30] | Transfusion in number of patients | n (%) | 111 (95%) | 113 (97%) | < 0.001 |